UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 544

Sortiert nach

Glutamate and α-ketoglutarate: key players in glioma metabolism

Amino acids, 2017-01, Vol.49 (1), p.21-32

2017

Volltextzugriff (PDF)

From 'Targeted Therapy' to Targeted Therapy

Anticancer research, 2019-07, Vol.39 (7), p.3341-3345

Peters, Godefridus J

2019

Volltextzugriff (PDF)

Nucleo(s)tide metabolism as basis for drug development; the Anne Simmonds award lecture

Nucleosides, nucleotides & nucleic acids, 2024-08, p.1-24

Peters, Godefridus J.

2024

Volltextzugriff (PDF)

Pharmacokinetics and pharmacogenetics of Gemcitabine as a mainstay in adult and pediatric oncology: an EORTC-PAMM perspective

Cancer Chemotherapy and Pharmacology, 2016-07, Vol.78 (1), p.1-12

2016

Volltextzugriff (PDF)

Heterogeneity and plasticity of cancer-associated fibroblasts in the pancreatic tumor microenvironment

Seminars in cancer biology, 2022-07, Vol.82, p.184-196

2022

Volltextzugriff (PDF)

Platinum‐Induced Neurotoxicity and Preventive Strategies: Past, Present, and Future

The oncologist (Dayton, Ohio), 2015-04, Vol.20 (4), p.411-432

2015

Volltextzugriff (PDF)

Re-evaluation of Brequinar sodium, a dihydroorotate dehydrogenase inhibitor

Nucleosides, nucleotides & nucleic acids, 2018-12, Vol.37 (12), p.666-678

Peters, Godefridus J.

2018

Volltextzugriff (PDF)

Identification of microRNA-21 as a biomarker for chemoresistance and clinical outcome following adjuvant therapy in resectable pancreatic cancer

PloS one, 2010-05, Vol.5 (5), p.e10630

2010

Volltextzugriff (PDF)

Lactate Dehydrogenase and its clinical significance in pancreatic and thoracic cancers

Seminars in cancer biology, 2022-11, Vol.86, p.93-100

2022

Volltextzugriff (PDF)

Combination of HGF/MET-targeting agents and other therapeutic strategies in cancer

Critical reviews in oncology/hematology, 2021-04, Vol.160, p.103234-103234, Article 103234

2021

Volltextzugriff (PDF)

Molecular targets of gemcitabine action: rationale for development of novel drugs and drug combinations

Current pharmaceutical design, 2012-06, Vol.18 (19), p.2811

2012

Volltextzugriff (PDF)

Targeting miRNA and using miRNA as potential therapeutic options to bypass resistance in pancreatic ductal adenocarcinoma

Cancer and metastasis reviews, 2023-09, Vol.42 (3), p.725-740

2023

Volltextzugriff (PDF)

The role of Eph receptors in cancer and how to target them: novel approaches in cancer treatment

Expert opinion on investigational drugs, 2020-06, Vol.29 (6), p.567-582

2020

Volltextzugriff (PDF)

Transporter and Lysosomal Mediated (Multi)drug Resistance to Tyrosine Kinase Inhibitors and Potential Strategies to Overcome Resistance

Cancers, 2018-12, Vol.10 (12), p.503

2018

Volltextzugriff (PDF)

GSK3β as a novel promising target to overcome chemoresistance in pancreatic cancer

Drug resistance updates, 2021-09, Vol.58, p.100779-100779, Article 100779

2021

Volltextzugriff (PDF)

FOLFIRINOX and translational studies: Towards personalized therapy in pancreatic cancer

World journal of gastroenterology : WJG, 2016-08, Vol.22 (31), p.6987-7005

2016

Volltextzugriff (PDF)

Looking for the unexpected in purine and pyrimidine metabolism

Nucleosides, nucleotides & nucleic acids, 2023-10, p.1-9

2023

Volltextzugriff (PDF)

Molecular mechanisms underlying the role of microRNAs (miRNAs) in anticancer drug resistance and implications for clinical practice

Critical reviews in oncology/hematology, 2012-02, Vol.81 (2), p.103-122

2012

Volltextzugriff (PDF)

New insights in research on purine and pyrimidine metabolism

Nucleosides, nucleotides & nucleic acids, 2022, Vol.41 (3), p.247-254

2022

Volltextzugriff (PDF)

Cyclin Dependent Kinase-1 (CDK-1) Inhibition as a Novel Therapeutic Strategy against Pancreatic Ductal Adenocarcinoma (PDAC)

Cancers, 2021-08, Vol.13 (17), p.4389

2021

Volltextzugriff (PDF)

A New Oxadiazole-Based Topsentin Derivative Modulates Cyclin-Dependent Kinase 1 Expression and Exerts Cytotoxic Effects on Pancreatic Cancer Cells

Molecules (Basel, Switzerland), 2021-12, Vol.27 (1), p.19

2021

Volltextzugriff (PDF)

Can cytidine deaminase be used as predictive biomarker for gemcitabine toxicity and response?

British journal of clinical pharmacology, 2019-06, Vol.85 (6), p.1213-1214

2019

Volltextzugriff (PDF)

Folate receptors and transporters: biological role and diagnostic/therapeutic targets in cancer and other diseases

Journal of experimental & clinical cancer research, 2019-03, Vol.38 (1), p.125-125, Article 125

2019

Volltextzugriff (PDF)

Efficacy of thioguanine treatment in inflammatory bowel disease: A systematic review

World journal of gastroenterology : WJG, 2016-10, Vol.22 (40), p.9012-9021

2016

Volltextzugriff (PDF)

Hype or hope – Can combination therapies with third-generation EGFR-TKIs help overcome acquired resistance and improve outcomes in EGFR-mutant advanced/metastatic NSCLC?

Critical reviews in oncology/hematology, 2021-10, Vol.166, p.103454-103454, Article 103454

2021

Volltextzugriff (PDF)

1 – 25 von 544

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(494)
Mit Volltextzugriff
(477)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(544)
Japanisch
(62)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(388)
Life Sciences & Biomedicine
(380)
Humans
(313)
Oncology
(195)
Biological And Medical Sciences
(124)
Medical Sciences
(121)
Pharmacology & Pharmacy
(116)
Female
(107)
Pharmacology. Drug Treatments
(104)
Animals
(93)
Antineoplastic Agents
(92)
Biochemistry & Molecular Biology
(80)
Cell Line, Tumor
(72)
Deoxycytidine - Analogs & Derivatives
(69)
Male
(68)
Tumors
(65)
Chemotherapy
(63)
Tumor Cells, Cultured
(61)
Antineoplastic Agents - Pharmacology
(56)
Mice
(51)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Glutamate and α-ketoglutarate: key players in glioma metabolism

From 'Targeted Therapy' to Targeted Therapy

Nucleo(s)tide metabolism as basis for drug development; the Anne Simmonds award lecture

Pharmacokinetics and pharmacogenetics of Gemcitabine as a mainstay in adult and pediatric oncology: an EORTC-PAMM perspective

Heterogeneity and plasticity of cancer-associated fibroblasts in the pancreatic tumor microenvironment

Platinum‐Induced Neurotoxicity and Preventive Strategies: Past, Present, and Future

Re-evaluation of Brequinar sodium, a dihydroorotate dehydrogenase inhibitor

Identification of microRNA-21 as a biomarker for chemoresistance and clinical outcome following adjuvant therapy in resectable pancreatic cancer

Lactate Dehydrogenase and its clinical significance in pancreatic and thoracic cancers

Combination of HGF/MET-targeting agents and other therapeutic strategies in cancer

Molecular targets of gemcitabine action: rationale for development of novel drugs and drug combinations

Targeting miRNA and using miRNA as potential therapeutic options to bypass resistance in pancreatic ductal adenocarcinoma

The role of Eph receptors in cancer and how to target them: novel approaches in cancer treatment

Transporter and Lysosomal Mediated (Multi)drug Resistance to Tyrosine Kinase Inhibitors and Potential Strategies to Overcome Resistance

GSK3β as a novel promising target to overcome chemoresistance in pancreatic cancer

FOLFIRINOX and translational studies: Towards personalized therapy in pancreatic cancer

Looking for the unexpected in purine and pyrimidine metabolism

Molecular mechanisms underlying the role of microRNAs (miRNAs) in anticancer drug resistance and implications for clinical practice

New insights in research on purine and pyrimidine metabolism

Cyclin Dependent Kinase-1 (CDK-1) Inhibition as a Novel Therapeutic Strategy against Pancreatic Ductal Adenocarcinoma (PDAC)

A New Oxadiazole-Based Topsentin Derivative Modulates Cyclin-Dependent Kinase 1 Expression and Exerts Cytotoxic Effects on Pancreatic Cancer Cells

Can cytidine deaminase be used as predictive biomarker for gemcitabine toxicity and response?

Folate receptors and transporters: biological role and diagnostic/therapeutic targets in cancer and other diseases

Efficacy of thioguanine treatment in inflammatory bowel disease: A systematic review

Hype or hope – Can combination therapies with third-generation EGFR-TKIs help overcome acquired resistance and improve outcomes in EGFR-mutant advanced/metastatic NSCLC?

Suchergebnisse filtern